1-47416320-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012186.3(FOXE3):āc.5C>Gā(p.Ala2Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000149 in 1,342,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. A2A) has been classified as Likely benign.
Frequency
Consequence
NM_012186.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXE3 | NM_012186.3 | c.5C>G | p.Ala2Gly | missense_variant | 1/1 | ENST00000335071.4 | |
LINC01389 | NR_126355.1 | n.29-6419G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXE3 | ENST00000335071.4 | c.5C>G | p.Ala2Gly | missense_variant | 1/1 | NM_012186.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151010Hom.: 0 Cov.: 32
GnomAD4 exome AF: 8.39e-7 AC: 1AN: 1191712Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 582282
GnomAD4 genome AF: 0.00000662 AC: 1AN: 151010Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73628
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2024 | The p.A2G variant (also known as c.5C>G), located in coding exon 1 of the FOXE3 gene, results from a C to G substitution at nucleotide position 5. The alanine at codon 2 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at